An HIV-1 encoded peptide mimics the DNA binding loop of NF-κB and binds thioredoxin with high affinity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 579, Issue 1-2, 2005, Pages 133-148

  Su, Guoping ^a,c   Min, Wang ^b   Taylor, Ethan Will ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Frameshift; HIV 1 protease; Nuclear factor kappa B (NF B); Selenoprotein; Thioredoxin

Indexed keywords

CYSTEINE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; OLIGOMER; PHORBOL 13 ACETATE 12 MYRISTATE; SELENOCYSTEINE; SELENOPROTEIN; SERINE; THIOREDOXIN; TRANSCRIPTION FACTOR REL; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIUM; BINDING AFFINITY; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; EMBRYO; FEMALE; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STIMULATION; WILD TYPE;

ANIMALS; BINDING SITES; CELLS, CULTURED; CYSTEINE; ESCHERICHIA COLI; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLUTATHIONE TRANSFERASE; HIV-1; HUMANS; IMMUNOPRECIPITATION; MAMMALS; MOLECULAR MIMICRY; MUTATION; NF-KAPPA B; PEPTIDES; RETROVIRIDAE PROTEINS; THIOREDOXIN;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 27544515134     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.02.019     Document Type: Article

References (67)

1. E.W. Taylor, C.S. Ramanathan, R.K. Jalluri, and R.G. Nadimpalli A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression J. Med. Chem. 37 1994 2637 2654
2. E.W. Taylor, R.G. Nadimpalli, and C.S. Ramanathan Genomic structures of viral agents in relation to the biosynthesis of selenoproteins Biol. Trace. Elem. Res. 56 1997 63 91
3. M.J. Berry, L. Banu, J.W. Harney, and P.R. Larsen Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons EMBO J. 12 1993 3315 3322
4. A. Bock, K. Forchhammer, J. Heider, W. Leinfelder, G. Sawers, B. Veprek, and F. Zinoni Selenocysteine: the 21st amino acid Mol. Microbiol. 5 1991 515 520
5. Q. Shen, F.F. Chu, and P.E. Newburger Sequences in the 3′-untranslated region of the human cellular glutathione peroxidase gene are necessary and sufficient for selenocysteine incorporation at the UGA codon J. Biol. Chem. 268 1993 11463 11469
6. E.W. Taylor, A.A. Bhat, R.G. Nadimpalli, W. Zhang, and J. Kececioglu HIV-1 encodes a sequence overlapping env gp41 with highly significant similarity to selenium-dependent glutathione peroxidases J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 15 1997 393 394
7. E.W. Taylor, A.G. Cox, L. Zhao, J.A. Ruzicka, A.A. Bhat, W. Zhang, R.G. Nadimpalli, and R.G. Dean Nutrition HIV, and drug abuse: the molecular basis of a unique role for selenium J. Acquir. Immune. Defic. Syndr. 25 Suppl. 1 2000 S53 S61
8. E.W. Taylor, C.S. Ramanathan, and R.G. Nadimpalli A general method for predicting potential new genes in nucleic acid sequences: application to the human immunodeficiency virus M. Witten Computational Medicine 1996 Public Health and Biotechnology, World Scientific 285 309
9. J. Qin, G.M. Clore, W.M. Kennedy, J.R. Huth, and A.M. Gronenborn Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF-κB Structure 3 1995 289 297
10. B.A. Antoni, S.B. Stein, and A.B. Rabson Regulation of human immunodeficiency virus infection: implications for pathogenesis Adv. Virus Res. 43 1994 53 145
11. P. Baeuerle, and D. Baltimore A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB Genes Dev. 3 1989 1689 1698
12. D.P. Bednarik, and T.M. Folks Mechanisms of HIV-1 latency AIDS 6 1992 3 16
13. S. Doerre, P. Sista, S. Sun, D. Ballard, and W. Greene The c-rel protooncogene product represses NF-{kappa}B p65-mediated transcriptional activation of the long terminal repeat of Type 1 human immunodeficiency virus PNAS 90 1993 1023 1027
14. K. Kawakami, C. Scheidereit, and R.G. Roeder Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro PNAS 85 1988 4700 4704
15. A.B. Rabson, and H.-C. Lin NF-κB and HIV: linking viral and immune activation K.-T. Jeang HIV-1: Molecular Biology and Pathogenesis - Viral Mechanisms 2000 Academic Press 161 207
16. A.S. Baldwin The NF-κB and IKB proteins: new discoveries and insights Annu. Rev. Immunol. 14 1996 649 681
17. P.A. Baeuerle, and D. Baltimore NF-κB: ten years after Cell 87 1996 13 20
18. G. Biswas, H.K. Anandatheerthavarada, M. Zaidi, and N.G. Avadhani Mitochondria to nucleus stress signaling: a distinctive mechanism of NF{kappa}B/Rel activation through calcineurin-mediated inactivation of I{kappa}B{beta} J. Cell Biol. 161 2003 507 519
19. U. Siebenlist, G. Fransozo, and K. Brown Structure, regulation and function of NF-κB Annu. Rev. Cell Biol. 10 1994 405 430
20. I. Stancovski, and D. Baltimore NF-κB activation: the IKB kinase revealed Cell 91 1997 299 302
21. B. Tian, and A.R. Brasier Identification of a nuclear factor kappa B-dependent gene network Recent Prog. Horm. Res. 58 2003 95 130
22. G. Waris, A. Livolsi, V. Imbert, J. Peyron, and A. Siddiqui Hepatitis C virus NS5A and subgeomic replicons activate NF-κB via tyrosine phosphorylation of IkBa and its degradation by calpain protease J. Biol. Chem. 2003 M303248200
23. G.E. Griffin, K. Leung, T.M. Folks, S. Kunkel, and G.J. Nabel Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B Nature 339 1989 70 73
24. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J. 10 1991 2247 2258
25. R. Schreck, K. Albermann, and P. Bauerle Nuclear factor κB: an oxidative stress-response transcription factor of eukaryotic cells Free Rad. Res. Comm. 17 1992 221 237
26. K. Schulze-Osthoff, R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF EMBO J. 12 1993 3095 3104
27. K. Mitomo, K. Nakayama, K. Fujimoto, X. Sun, S. Seki, and K. Yamamoto Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro Gene 145 1994 197 203
28. A. Beg, T. Finco, P. Nantermet, and A. Baldwin Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation Mol. Cell. Biol. 13 1993 3301 3310
29. T. Henkel, T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P.A. Baeuerle Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B Nature 365 1993 182 185
30. C. Kretz-Remy, P. Mehlen, M. Mirault, and A. Arrigo Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression J. Cell Biol. 133 1996 1083 1093
31. V. Makropoulos, T. Briining, and K. Schulze-Osthoff Selenium-mediated inhibition of transcription factor NF kappa B and HIV-1 LTR promoter activity Arch. Toxicol. 70 1996 277 283
32. Y.J. Suzuki, B.B. Aggarwal, and L. Packer Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells Biochem. Biophys. Res. Commun. 189 1992 1709 1715
33. J.-P. Yang, J.P. Merina, T. Nakanoa, T. Katoa, Y. Kitadeb, and T. Okamoto Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro FEBS Lett. 361 1995 89 96
34. R.A. Sunde Selenium B.L. O'Dell R.A. Sunde Handbook of Nutritionally Essential Minerals 1997 Marcel Dekker New York 493 556
35. C. Allavena, B. Dousset, T. May, F. Dubois, P. Canton, and F. Belleville Relationship of trace-element, immunological markers, and HIV infection progression Biol. Trace Elem. Res. 47 1995
36. M.A. Beck, Q. Shi, V.C. Morris, and O.A. Levander Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates Nat. Med. 1 1995 433 436
37. M.K. Baum, G. Shor-posner, S. Lai, G. Zhang, H. Lai, M.A. Fletcher, H. Sauberlich, and J.B. Page High risk of HIV-related mortality is associated with selenium deficiency J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 15 1997 370 376
38. J. Constans, J.L. Pellegrin, C. Sergeant, M. Simonoff, I. Pellegrin, H. Fleury, B. Leng, and C. Conri Serum selenium predicts outcome in HIV infection J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10 1995 392
39. B.M. Dworkin Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS) Chem. Biol. Interact. 91 1994 181 186
40. S.Y. Yu, Y.J. Zhu, and W.G. Li Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong Biol. Trace Elem. Res. 56 1997 117 124
41. M.W. Yu, I.S. Horng, K.H. Hsu, Y.C. Chiang, Y.F. Liaw, and C.J. Chen Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection Am. J. Epidemiol. 150 1999 367 374
42. K. Hori, D. Hatfield, F. Maldarelli, B.J. Lee, and K.A. Clouse Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro AIDS Res. Hum. Retroviruses 13 1997 1325 1332
43. R. Brigelius-Flohe, B. Friedrichs, S. Maurer, M. Schultz, and R. Streicher Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line Biochem. J. 328 1997 199 203
44. L. Hori, D. Hatfield, F. Maldarelli, B.J. Lee, and K.A. Clouse Selenium supplementation suppresses tumor necrosis factor α-induced human immunodeficiency virus type 1 replication in vitro AIDS Res. Hum. Retroviruses 13 1997 1325 1332
45. C. Sappey, S. Legrand-Poels, M. Best-Belpomme, A. Favier, B. Rentier, and J. Piette Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress AIDS. Res. Hum. Retroviruses 10 1994 1451 1461
46. A. Gallegos, M. Berggren, J. Gasdaska, and G. Powis Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium Cancer Res. 57 1997 4965 4970
47. K.B. Hadley, and R.A. Sunde Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver J. Nutr. Biochem. 12 2001 693 702
48. K. Hirota, M. Murata, Y. Sachi, H. Nakamura, J. Takeuchi, K. Mori, and J. Yodoi Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappa B J. Biol. Chem. 274 1999 27891 27897
49. Y. Liu, and W. Min Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK 1-mediated apoptosis in a redox activity-independent manner Circ. Res. 90 2002 1259 1266
50. T. Tanaka, H. Nakamura, A. Nishiyama, F. Hosoi, H. Masutani, H. Wada, and J. Yodoi Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging Free Radic. Res. 33 2000 851 855
51. E.S.J. Arner, and A. Holmgren Physiological functions of thioredoxin and thioredoxin reductase Eur. J. Biochem. 267 2000 6102 6109
52. G. Powis, D. Mustacich, and A. Coon The role of the redox protein thioredoxin in cell growth and cancer Free Radic. Biol. Med. 29 2000 312 322
53. J.R. Matthews, N. Wakasugi, J. Virelizier, J. Yodoi, and R.T. Hay Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62 Nucleic Acids Res. 20 1992 3821 3830
54. A.K. Kenworthy Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy Methods 24 2001 289 296
55. F.S. Wouters, P.J. Verveer, and P.I.H. Bastiaens Imaging biochemistry inside cells Trends Cell Biol. 11 2001 203 211
56. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 PNAS 94 1997 3633 3638
57. M. Bjornstedt, S. Kumar, L. Bjorkhem, G. Spyrou, and A. Holmgren Selenium and the thioredoxin and glutaredoxin systems Biomed. Environ. Sci. 10 1997 271 279
58. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
59. R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W.C. Greene HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell Nature 410 2001 834 838
60. Y. Li, G. Mak, and B. Franza Jr. In vitro study of functional involvement of Spl, NF-kappa B/Rel, and API inphorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation J. Biol. Chem. 269 1994 30616 30619
61. A. Varin, S.K. Manna, V. Quivy, A.-Z. Decrion, C. Van Lint, G. Herbein, and B.B. Aggarwal Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis J. Biol. Chem. 278 2003 2219 2227
62. V.N. Gladyshev, M. Krause, X.-M. Xu, K.V. Korotkov, G.V. Kryukov, Q.-A. Sun, B.J. Lee, J.C. Wootton, and D.L. Hatfield Selenocysteine-containing thioredoxin reductase in C. elegans Biochem. Biophys. Res. Commun. 259 1999 244 249
63. T.G. Senkevich, J.J. Bugert, J.R. Sisler, E.V. Koonin, G. Darai, and B. Moss Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes Science 273 1996 813 816
64. J.L. Shisler, T.G. Senkevich, M.J. Berry, and B. Moss Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus Science 279 1998 102 105
65. L. Zhao, A.G. Cox, J.A. Ruzicka, A.A. Bhat, W. Zhang, and E.W. Taylor Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase Proc. Natl. Acad. Sci. U.S.A. 97 2000 6356 6361
66. I. Cohen, P. Boya, L. Zhao, D. Metivier, K. Andreau, J.-L. Perfettini, J.G. Weaver, A. Badley, E.W. Taylor, and G. Kroemer Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1 Apoptosis 9 2004 181 192
67. V.N. Gladyshev, T.C. Stadtman, D.L. Hatfield, and K.-T. Jeang Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase PNAS 96 1999 835 839